相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome The STOPDAPT-2 ACS Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA CARDIOLOGY (2022)
Absolute vs. relative effects-implications for subgroup analyses
Lars W. Andersen
TRIALS (2021)
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI An Individual Patient-Level Meta-Analysis
Marco Valgimigli et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2021)
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention Insight From the STOPDAPT-2 Trial
Ko Yamamoto et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
Ji Woong Roh et al.
CARDIOLOGY JOURNAL (2021)
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity
Harmony R. Reynolds et al.
CIRCULATION (2021)
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Acute Coronary Syndrome Patients With a High Risk of Ischemic Events
Seung-Jun Lee et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
Raffaele Piccolo et al.
EUROINTERVENTION (2021)
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Ticagrelor With or Without Aspirin After Complex Percutaneous Coronary Intervention
George Dangas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial
Byeong-Keuk Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
Francesco Costa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials
Raffaele Piccolo et al.
LANCET (2019)
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
Patrick W. Serruys et al.
EUROPEAN HEART JOURNAL (2019)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
Anna Franzone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
From bare metal to barely anything: an update on coronary stenting
Raffaele Piccolo et al.
HEART (2018)
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPIONPHOENIX trial
Gregg W. Stone et al.
EUROPEAN HEART JOURNAL (2018)
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx et al.
LANCET (2018)
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Janusz Lipiecki et al.
EUROINTERVENTION (2018)
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy An Individual Participant Data Analysis
Raffaele Piccolo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Robert W. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
David J. Fisher et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
David J. Fisher et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
Gennaro Giustino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease A Patient-Level Pooled Analysis of 6,081 Patients
Raffaele Piccolo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia
G. B. John Mancini et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
How to Use a Subgroup Analysis
Xin Sun et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)
Giulio G. Stefanini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
分享论文
